Effect of novel oral anticoagulants on Hospital Anxiety and Depression Scale scores


Cosansu K., Ureyen C. M., Yilmaz S.

HERZ, cilt.44, sa.8, ss.743-749, 2019 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 44 Sayı: 8
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1007/s00059-019-4828-1
  • Dergi Adı: HERZ
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.743-749
  • Kütahya Sağlık Bilimleri Üniversitesi Adresli: Hayır

Özet

Background. The negative impact of atrial fibrillation (AF) on health-related quality of life has been extensively documented. The aim of this study was to compare the Hospital Anxiety and Depression Scale (HADS) scores of patients with non-valvular AF during warfarin administration and after switching to novel oral anticoagulants (NOACs).